Clinical trial
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family…
NCT00031850 · Institute of Cancer Research, United Kingdom, Other · Completed
Key facts
| NCT number | NCT00031850 |
|---|---|
| Title | Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer |
| Official title | A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | goserelin acetate, raloxifene |
| Enrollment | 150 |
| Start date | Mar 1, 2000 |
| Completion | May 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: